Oncology/preventive medicine

Question 1

tamoxifen toxicitiy

Answer 1

endometrial cancer

clots

Question 2

aromatase inhibitos tox

Answer 2

osteoporosis

Question 3

traztuzumab

Answer 3

decreases risk and recurrent disease

Question 4

adjuvant chemotherapy indication

Answer 4

1-.lesions larger than 1 cm

2-.positice axillary lymph nodes are found

Question 5

lower mortality in breast cancer

Answer 5

• mammography
• ER/PR testing,then tamoxifen/raloxifen
• aromatase inhibitor
• adjunvant chemoterapy
• lympectomy and radiation
• modified radical mastectomy
• trastuzumab
• prophylaxis with tamoxifen

Question 6

lung cancer screening

Answer 6

low dose chest CT in a patient with 30 pack-years smoking history YEARLY from 55-80

Question 7

HPV vaccine indication

Answer 7

every womenbetween ages 11-26

Question 8

pap smear infiaction

Answer 8

after 21 every 3 years, or every 5 if HPV DNA testing its made. STOP at 65

Question 9

ASCUSn + … next step

Answer 9

do a HPV DNA test,

-if positive colposcopy.

Question 10

brest cancer screening indication

Answer 10

startin al 4o every 2 year, stop at 75

Question 11

colonoscopy screening

Answer 11

every 10 years after 50 years

Question 12

shingles vaccine indication

Answer 12

everyone over 60

Question 13

Td indication

Answer 13

every 10 years

Question 14

osteoporsosis screening indication

Answer 14

women>65 DEXA

Question 15

AAA indication

Answer 15

all men ever smoking at 65

Question 16

lipid screening indication

Answer 16

men over 35

women over 45

Question 17

screening for diabetes

Answer 17

any patient with hypertension or hyperlipidemia

GENERAL POPULATION IS NO CLEAR

Question 18

patient over 50

Answer 18

use inactivated (DEAD) flu vaccine

Question 19

hepatitis B vaccine indication

Answer 19

• end stage renla disease( dialysis)
• healthcare workers
• diabetes

Question 20

hepatitis A vaccine indication

Answer 20

travelers to coundtries of high endemicity

Question 21

DEXA scan indication

Answer 21

at the age of 65

Question 22

most common finding lipid profile in methabolic syndrome

Answer 22

increase TGC and low HDL

Question 23

Live vaccines

Answer 23

• MMR
• zoster
• varicella
• live influenza

Question 24

Malarie prophylaxis for chloroquine-sensitive areas(CENTRAL AMERICA)

• caribean
• mexico
• costarica
• argetina
• el salvador
• paraguay

Answer 24

• chloroquine
• atovaquone/proguanil(co traindicated in Renal clearance below 30)
• doxycycline

Question 25

malarie prophylaxis for chloroquine-resistent areas

Answer 25

- mefloquine | - doxycycline

Question 26

screening for all sexually active women under 25

Answer 26

- PCR for N.gonorrhea and chlamydia | - HIV

Question 27

what to do with a colon polyps?

Answer 27

rmeove any polyp larger than 1cm

Question 28

most sensitive modality for ovarian cancer

Answer 28

CA125 conviened with a transvaginal ultrasound

Question 29

raloxifeno

Answer 29

prevention and treament of osteporosis

Question 30

asthma patients vaccination

Answer 30

-inactivated influenza and pneumocco vaccine

Question 31

patients who should recive the inactivated form of influenza insted of the activated

Answer 31

- inmunocompromised - cardiovascular, pulmanary,metabollic disease - guillina barre - pregnant

Question 32

barret esophagous followin after endoscopy finding: - WITHOUT dysplasia: - LOW dysplasia: - HIGH dysplasia:

Answer 32

- WITHOUT dysplasia: endoscopy every 3 years - LOW dysplasia: every 6 to 12 m - HIGH dysplasia:every 3 month

Question 33

smoking sesation aid

Answer 33

nicotine patch and gums as needed

Question 34

if you dont know the inmunization status what to choose: | Td or TdaP?

Answer 34

if you dont know give TdaP and inmunoglobulin

Question 35

tetanus vaccination

Answer 35

- CONTAMINATED with dirt,feces,soil or salive(like a bite), requires a tetanus vaccination if the last one was more than 5 years. - clean wound 10 years

Question 36

when to screen HNPCC(2 generations, 1 premature)

Answer 36

-Colonoscopy at 25 years(YEARLY)

Question 37

FAP when to screen?

Answer 37

-SIGMOIDOSCOPY at 12 y

Question 38

when to screen with previous adenomatous poly

Answer 38

-COLONOSCOPY every 3-5 Y

Question 39

previos colon cancer history when to screen

Answer 39

-COLONOSCOPY 1 year,then at 3years, and every 5 years.

Question 40

Heb B indication | 3 dosis

Answer 40

- Birth - 2m - 6m

Question 41

Rotavirus(2 dosis)

Answer 41

- 2m | - 4m

Question 42

DTaP(5 doses)

Answer 42

- 2m - 4m - 6m - 15m - 6y

Question 43

Hib(4 doses)

Answer 43

- 2m - 4m - 1y - 15m

Question 44

PVC13(4 doses)

Answer 44

-2m -4m -6m 1y

Question 45

polio (SALK) 4 doses

Answer 45

- 2m - 4m - 6m - 6y

Question 46

MMR(2 doses)

Answer 46

- 1y | - 6y

Question 47

VAR

Answer 47

- 1y | - 6y

Question 48

hepA

Answer 48

-1y

Question 49

meningococcal

Answer 49

-11y

Question 50

vaccine at birth

Answer 50

HepB

Question 51

vaccines at 2 months(6 vaccines)

Answer 51

- HepB - rotavirus - DTaP - Hib - PVC13 - polio (SALK)

Question 52

vaccines at 4 months(5 doses)

Answer 52

- RV - DTaP - Hib - PVC13 - SALK

Question 53

vaccines at 6 months(3 dosis)

Answer 53

- HepB - DTaP - PVC13 - SALK

Question 54

live vaccines

Answer 54

- MMR - sabin(polio) - yellow fever - influenza(nasal)

Question 55

killed vaccines

Answer 55

- cholera - HAV - SALK - rabies - influenza(IM)

Question 56

what happens if you lower the cut off point

Answer 56

-INCREASE IN SENSITIVITY | increase in True positive

Question 57

what happens if you increase the cut off point

Answer 57

-INCREASE IN SPECIFICITY

Question 58

type 1 errer(alphs)

Answer 58

false postive(null hypothesis is incorrectly rejected)

Question 59

type II error(betha)

Answer 59

false negative (null hypothesis is not rejected when it is in fact false)

Question 60

Relative rist over 1

Answer 60

disease is more likely to occur in the exposed group

Question 61

reative risk under 1

Answer 61

disease is less likely to occur in the exposed group (PROTECTIVE)